MDXXF
Price
$0.11
Change
-$0.01 (-8.33%)
Updated
Apr 30 closing price
Capitalization
12.51M
ZIVO
Price
$13.79
Change
-$4.21 (-23.39%)
Updated
May 2 closing price
Capitalization
51.84M
Ad is loading...

MDXXF vs ZIVO

Header iconMDXXF vs ZIVO Comparison
Open Charts MDXXF vs ZIVOBanner chart's image
PharmAla Biotech Holdings
Price$0.11
Change-$0.01 (-8.33%)
Volume$5K
Capitalization12.51M
Zivo Bioscience
Price$13.79
Change-$4.21 (-23.39%)
Volume$557
Capitalization51.84M
MDXXF vs ZIVO Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDXXF vs. ZIVO commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXXF is a Hold and ZIVO is a Hold.

Ad is loading...
COMPARISON
Comparison
May 05, 2025
Stock price -- (MDXXF: $0.11 vs. ZIVO: $13.79)
Brand notoriety: MDXXF and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDXXF: 23% vs. ZIVO: 86%
Market capitalization -- MDXXF: $12.51M vs. ZIVO: $51.84M
MDXXF [@Biotechnology] is valued at $12.51M. ZIVO’s [@Biotechnology] market capitalization is $51.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXXF’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • MDXXF’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, both MDXXF and ZIVO are a bad buy in the long-term.

Price Growth

MDXXF (@Biotechnology) experienced а +12.38% price change this week, while ZIVO (@Biotechnology) price change was -26.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

ZIVO is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ZIVO($51.8M) has a higher market cap than MDXXF($12.5M). MDXXF (-35.389) and ZIVO (-35.860) have similar YTD gains . MDXXF has higher annual earnings (EBITDA): -1.21M vs. ZIVO (-13.66M). MDXXF has more cash in the bank: 199K vs. ZIVO (159K). MDXXF has higher revenues than ZIVO: MDXXF (340K) vs ZIVO (79K).
MDXXFZIVOMDXXF / ZIVO
Capitalization12.5M51.8M24%
EBITDA-1.21M-13.66M9%
Gain YTD-35.389-35.86099%
P/E RatioN/AN/A-
Revenue340K79K430%
Total Cash199K159K125%
Total DebtN/A377K-
FUNDAMENTALS RATINGS
ZIVO: Fundamental Ratings
ZIVO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
DAR.X0.001051-0.000026
-2.42%
Digital Asset Rights Token cryptocurrency
INJ.X9.297609-0.359600
-3.72%
Injective cryptocurrency
MAGIC.X0.171800-0.006963
-3.90%
Treasure cryptocurrency
KMD.X0.135003-0.006104
-4.33%
Komodo cryptocurrency
RVN.X0.010451-0.000770
-6.86%
Ravencoin cryptocurrency

MDXXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXXF has been loosely correlated with NICXF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXXF jumps, then NICXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXXF
1D Price
Change %
MDXXF100%
N/A
NICXF - MDXXF
46%
Loosely correlated
N/A
ABVC - MDXXF
25%
Poorly correlated
+1.94%
ZIVO - MDXXF
23%
Poorly correlated
-23.39%
KNSA - MDXXF
20%
Poorly correlated
-0.32%
VYGR - MDXXF
20%
Poorly correlated
+2.54%
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and APLM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and APLM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
-23.39%
APLM - ZIVO
28%
Poorly correlated
-3.52%
LGVN - ZIVO
24%
Poorly correlated
N/A
MDXXF - ZIVO
24%
Poorly correlated
N/A
AKRO - ZIVO
23%
Poorly correlated
-0.97%
ATOS - ZIVO
23%
Poorly correlated
+1.47%
More